Changing US FDA trial default a global matter

FierceBiotechAgenus focuses on survival data as 0% response rate triggers primary miss

FierceBiotechOdyssey charts fresh voyage to public markets after abandoning IPO plans last year

FierceBiotechAstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win

MedtronicWire-free artery assessment tech joins Medtronic in $585M deal - Stock Titan

MedtronicPulnovo completes $100m financing round with Medtronic investment - Yahoo Finance

PfizerPfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha

MedtronicMedtronic, Pulnovo Join Forces On Pulmonary Denervation After $100M Financing - Citeline News & Insights

MedtronicPulnovo Medical: $100 Million Raised From Medtronic For Pulmonary Hypertension And Heart Failure Therapies - Pulse 2.0

Merck & Co.TD Waterhouse Canada Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat

Siemens HealthineersScreenPoint Medical raises $16m with continued investment from Siemens Healthineers - Medical Device Network

MedtronicMedtronic leads $100M financing for artery denervation tech developer Pulnovo Medical - MassDevice

WuXi AppTecHow WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients - Fierce Biotech